The Ranbaxy Story

It Took A Sleeping Pill A Get A Somnolent Company Up And Running. The Drug Was Calmpose Ranbaxy S Answer To Roche S Valium And Its Launch In 1969 Was The Hitherto Unknown Company S First Step On The Long Road To Global Stardom. India Accounts For A Tiny Fraction Of The World Pharmaceuticals Market Just 1.2 Per Cent. To Become Really Big, Ranbaxy Realized Early In Life, It Had To Go Global. But Success Doesn T Come Easy In The World Market Which Is Dominated By Players Like Pfizer, Novartis And Glaxosmithkline. With Each Of These Putting Billions Of Dollars Into Research Every Year, It Takes A Great Deal Of Courage And Wisdom To Venture Into Their Territory Markets Like The United States And Europe. The Ranbaxy Story Sets Down, For The First Time, Ranbaxy S Remarkable Journey From A Distributor Of Medicine To A Multinational Corporation, Deriving Over Eighty Per Cent Of Its Business From Outside India. It Is Also The Story Of The Singh Family, Of Bhai Mohan Singh S Dogged Pursuit To Expand The Company During The Licence-Permit-Quota Raj And Of Dr Parvinder Singh Who Was Convinced Way Back In The 1970S That Ranbaxy S Destiny Lay In The International Markets. Bhupesh Bhandari, A Business Journalist Who Has Followed The Company Closely For Over A Decade, Traces Ranbaxy S Growth Against The Backdrop Of The Global Pharmaceutical Business. What Ensues Is A Riveting Account Of Human Ambition And Corporate Strategies In This Intimate Portrayal Of One Company S Rise To Success.